Vitamin D receptor fokI, BsmI, ApaI, and TaqI polymorphisms and the susceptibility to breast cancer: A meta-analysis

Neoplasma

Volumn 61, Issue 5, 2014, Pages 607-616

  Lee, Y H ^a   Song, G G ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Breast cancer; Meta analysis; Polymorphism; Vitamin D receptor

Indexed keywords

TAQ POLYMERASE; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; ENDODEOXYRIBONUCLEASE BSMI; ENDODEOXYRIBONUCLEASE FOKI; GGGCCC-SPECIFIC TYPE II DEOXYRIBONUCLEASES; TCGA-SPECIFIC TYPE II DEOXYRIBONUCLEASES; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CLINICAL EVALUATION; COMPARATIVE STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; INCIDENCE; META ANALYSIS; PUBLISHING; REGRESSION ANALYSIS; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS;

BREAST NEOPLASMS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RECEPTORS, CALCITRIOL;

EID: 84907296647     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_077     Document Type: Article

References (57)

1. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M Genetic susceptibility to breast cancer. Mol Oncol 2010; 4: 174–191. http://dx.doi.org/10.1016/j.molonc.2010.04.011
2. Maruotti N, Cantatore FP Vitamin D and the immune system. J Rheumatol 2010; 37: 491–495. http://dx.doi.org/10.3899/jrheum.090797
3. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974–4980. http://dx.doi.org/10.4049/jimmunol.167.9.4974
4. Villena-Heinsen C, Meyberg R, Axt-Fliedner R, Reitnauer K, REICHRATH J et al. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res 2002; 22: 2261–2267.
5. Deeb KK, Trump DL, Johnson CS Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684–700. http://dx.doi.org/10.1038/nrc2196
6. Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 1997; 11: 1165–1179. http://dx.doi.org/10.1210/mend.11.8.9951
7. Morrison NA, Yeoman R, Kelly PJ, Eisman JA Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A 1992; 89: 6665–6669. http://dx.doi.org/10.1073/pnas.89.15.6665
8. Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z et al. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One 2013; 8: e57967. http://dx.doi.org/10.1371/journal.pone.0057967
9. Fuhrman BJ, Freedman DM, Bhatti P, Doody MM, FU YP et al. Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res 2013; 33: 543–551.
10. Shahbazi S, Alavi S, Majidzadeh AK, Ghaffarpour M, Soleimani A et al. BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol 2013; 30: 393. http://dx.doi.org/10.1007/s12032-012-0393-7
11. Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U et al. Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2012; 21: 1856–1867. http://dx.doi.org/10.1158/1055-9965.EPI-12-0551
12. Dalessandri KM, Miike R, Wiencke JK, Farren G, Pugh TW et al. Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study. J Am Coll Surg 2012; 215: 652–657. http://dx.doi.org/10.1016/j.jamcollsurg.2012.06.413
13. Rollison DE, Cole AL, Tung KH, Slattery ML, Baumgartner KB et al. Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat 2012; 132: 683–691. http://dx.doi.org/10.1007/s10549-011-1885-4
14. Anderson LN, Cotterchio M, Cole DE, Knight JA Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev 2011; 20: 1708–1717. http://dx.doi.org/10.1158/1055-9965.EPI-11-0300
15. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev 2009; 32: 386–394. http://dx.doi.org/10.1016/j.canep.2009.04.012
16. Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T et al. Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat 2009; 115: 629–633. http://dx.doi.org/10.1007/s10549-008-0107-1
17. Mckay JD, Mccullough ML, Ziegler RG, Kraft P, Saltzman BS et al. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2009; 18: 297–305. http://dx.doi.org/10.1158/1055-9965.EPI-08-0539
18. Sinotte M, Rousseau F, Ayotte P, Dewailly E, Diorio C et al. Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer 2008; 15: 975–983. http://dx.doi.org/10.1677/ERC-08-0056
19. Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S et al. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 2008; 10: R31. http://dx.doi.org/10.1186/bcr1994
20. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 2007; 9: R9. http://dx.doi.org/10.1186/bcr1642
21. John EM, Schwartz GG, Koo J, Wang W, Ingles SA Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 2007; 166: 1409–1419. http://dx.doi.org/10.1093/aje/kwm259
22. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005; 41: 1164–1169. http://dx.doi.org/10.1016/j.ejca.2005.01.017
23. Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 2335–2339. http://dx.doi.org/10.1158/1055-9965.EPI-05-0283
24. Sillanpaa P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM et al. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics 2004; 14: 239–245. http://dx.doi.org/10.1097/00008571-200404000-00003
25. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res 2004; 10: 5472–5481. http://dx.doi.org/10.1158/1078-0432.CCR-04-0206
26. Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med 2003; 35: 550–555. http://dx.doi.org/10.1038/emm.2003.72
27. Hou MF, Tien YC, Lin GT, Chen CJ, Liu CS et al. Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat 2002; 74: 1–7. http://dx.doi.org/10.1023/A:1016048900049
28. Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE et al. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control 2000; 11: 25–30. http://dx.doi.org/10.1023/A:1008979417618
29. Lundin AC, Soderkvist P, Eriksson B, Bergmanjungestrom M, Wingren S Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 1999; 59: 2332–2334.
30. Dunning AM, Mcbride S, Gregory J, Durocher F, Foster NA et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 1999; 20: 2131–2135. http://dx.doi.org/10.1093/carcin/20.11.2131
31. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA et al. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 1999; 83: 723–726. http://dx.doi.org/10.1002/(SICI)1097-0215(19991210)83:6<723::AIDIJC4>3.0.CO;2-3
32. Nath SK, Harley JB, Lee YH Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 2005; 118: 225–234. http://dx.doi.org/10.1007/s00439-005-0044-6
33. Lee YH, Witte T, Momot T, Schmidt RE, Kaufman KM et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum 2005; 52: 3966–3974. http://dx.doi.org/10.1002/art.21484
34. Lee YH, Ji JD, Song GG Tumor necrosis factor-alpha promoter-308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 2007; 34: 43–49.
35. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558. http://dx.doi.org/10.1002/sim.1186
36. Egger M, Smith GD, Phillips AN Meta-analysis: principles and procedures. BMJ 1997; 315: 1533–1537. http://dx.doi.org/10.1136/bmj.315.7121.1533
37. Dersimonian R, Laird N Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188. http://dx.doi.org/10.1016/0197-2456(86)90046-2
38. Egger M, Davey Smith G, Schneider M, Minder C Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634. http://dx.doi.org/10.1136/bmj.315.7109.629
39. Mostowska A, Sajdak S, Pawlik P, Lianeri M, Jagodzinski PP Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population. Genet Test Mol Biomarkers 2013; 17: 183–187. http://dx.doi.org/10.1089/gtmb.2012.0332
40. Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT et al. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer 2011; 128: 936–943. http://dx.doi.org/10.1002/ijc.25403
41. Tworoger SS, Gates MA, Lee IM, Buring JE, Titusernstoff L et al. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 2009; 69: 1885–1891. http://dx.doi.org/10.1158/0008-5472.CAN-08-3515
42. Lurie G, Wilkens LR, Thompson PJ, Mcduffie KE, Carney ME et al. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16: 2566–2571. http://dx.doi.org/10.1158/1055-9965.EPI-07-0753
43. Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I et al. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 2008; 260: 209–215. http://dx.doi.org/10.1016/j.canlet.2007.11.002
44. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009; 29: 3511–3536.
45. Ahn J, Albanes D, Berndt SI, Peters U, Chatterjee N et al. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009; 30: 769–776. http://dx.doi.org/10.1093/carcin/bgp055
46. Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 546–552.
47. Tamez S, Norizoe C, Ochiai K, Takahashi D, Shimojima A et al. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 2009; 101: 1957–1960. http://dx.doi.org/10.1038/sj.bjc.6605414
48. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 2007; 9: R84. http://dx.doi.org/10.1186/bcr1833
49. Vandevord PJ, Wooley PH, Darga LL, Severson RK, Wu B et al. Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat 2006; 100: 103–107. http://dx.doi.org/10.1007/s10549-006-9228-6
50. Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E et al. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 2004; 101: 264–269. http://dx.doi.org/10.1002/cncr.20361
51. Ruggiero M, Pacini S, Aterini S, Fallai C, Ruggiero C et al. Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncol Res 1998; 10: 43–46.
52. Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC et al. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res 2012; 14: R58. http://dx.doi.org/10.1186/bcr3162
53. Barroso E, Fernandez LP, Milne RL, Pita G, Sendagorta E et al. Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer 2008; 8: 385. http://dx.doi.org/10.1186/1471-2407-8-385
54. Raimondi S, Johansson H, Maisonneuve P, Gandini S Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009; 30: 1170–1180. http://dx.doi.org/10.1093/carcin/bgp103
55. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997; 12: 915–921. http://dx.doi.org/10.1359/jbmr.1997.12.6.915
56. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143–156. http://dx.doi.org/10.1016/j.gene.2004.05.014
57. Tang C, Chen N, Wu M, Yuan H, Du Y Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 2009; 117: 391–399. http://dx.doi.org/10.1007/s10549-008-0262-4